Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayathri R

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
Cancer Research|January 21, 2018
XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer PhenotypeMyron K Evans, Michael C Brown, Joseph Geradts, et al.
Chemical Science|June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic deliveryGayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
Xenotransplantation|June 21, 2019
The role of human CD46 in early xenoislet engraftment in a dual transplant modelKannan P Samy, Qimeng Gao, Robert Patrick Davis, et al.
Current Treatment Options in Oncology|April 18, 2026
The Current Cardio-Oncology Landscape Across AustraliaDaniel H Chen, Lloyd Butel-Simoes, Mitchum Bower, et al.
Biomaterials Science|April 29, 2024
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinityGayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, et al.
Cancer Letters|October 3, 2017
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cellsHelen O Oladapo, Michael Tarpley, Scott J Sauer, et al.
Breast Cancer Research and Treatment|February 12, 2020
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activityCharlotte Rypens, Melike Marsan, Christophe Van Berckelaer, et al.
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancerAmelia U Schirmer, Lucy M Driver, Megan T Zhao, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
NPJ Breast Cancer|January 19, 2022
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBCCharlotte Rypens, François Bertucci, Pascal Finetti, et al.
Cancer Research|January 21, 2018
XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer PhenotypeMyron K Evans, Michael C Brown, Joseph Geradts, et al.
Chemical Science|June 14, 2021
Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic deliveryGayathri R Ediriweera, Joshua D Simpson, Adrian V Fuchs, et al.
Xenotransplantation|June 21, 2019
The role of human CD46 in early xenoislet engraftment in a dual transplant modelKannan P Samy, Qimeng Gao, Robert Patrick Davis, et al.
Current Treatment Options in Oncology|April 18, 2026
The Current Cardio-Oncology Landscape Across AustraliaDaniel H Chen, Lloyd Butel-Simoes, Mitchum Bower, et al.
Biomaterials Science|April 29, 2024
Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinityGayathri R Ediriweera, Neville J Butcher, Ashok Kothapalli, et al.
Cancer Letters|October 3, 2017
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cellsHelen O Oladapo, Michael Tarpley, Scott J Sauer, et al.
Breast Cancer Research and Treatment|February 12, 2020
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activityCharlotte Rypens, Melike Marsan, Christophe Van Berckelaer, et al.
International Journal of Cancer|October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivoMichael A Morse, Junping Wei, Zachary Hartman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2021
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancerAmelia U Schirmer, Lucy M Driver, Megan T Zhao, et al.
Pageof 12